Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional Results available

Evaluate the Safety and Efficacy of OAS in Treating Severely Calcified Coronary Lesions

ClinicalTrials.gov ID: NCT01092416

Public ClinicalTrials.gov record NCT01092416. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 11:00 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Pivotal Trial to Evaluate the Safety and Efficacy of the Diamondback 360°® Orbital Atherectomy System in Treating De Novo, Severely Calcified Coronary Lesions (ORBIT II)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a prospective, single-arm, multi-center study to evaluate the safety and performance of the OAS in treating de novo, severely calcified coronary lesions in adult subjects. Study is going to enroll up to 429 subjects in up to 50 U.S. study sites. The primary safety endpoint is 30-day MACE and primary efficacy endpoint is procedural success. All subjects will be treated with the orbital atherectomy system and adjunctive stent. All subjects will be followed in clinic at 30 days. Additionally, all subjects will have an annual phone call or clinical follow up at each anniversary until study is closed.

Study identification

NCT ID
NCT01092416
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
Abbott Medical Devices
Industry
Enrollment
443 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 2010 (Type not available)
Primary completion
Jan 2013 (Actual)
Completion
Jan 2016 (Actual)
Last update posted
Jul 18, 2023

2010 – 2016

United States locations

U.S. sites
51
U.S. states
24
U.S. cities
46
Facility City State ZIP Site status
Trinity Hospital Birmingham Alabama 35213 —
Baptist Montgomery South Montgomery Alabama 36116 —
Mercy Gilbert Gilbert Arizona 85297 —
Cedar Sinai Los Angeles Beverly Hills California 90210 —
Good Samaritan Hospital Los Angeles California 90017 —
Eisenhower Medical Center Palm Springs California 92270 —
Desert Cardiology Center Rancho Mirage California 92270 —
Sutter Memorial Hospital Sacramento California 95825 —
Florida Hospital Memorial Daytona Beach Florida 32117 —
North Florida Regional Gainesville Florida 32614 —
Munroe Regional Medical Center Ocala Florida 34471 —
Florida Hospital Orlando Florida 32803 —
Orlando Regional Orlando Florida 32806 —
Palm Beach Gardens Palm Beach Gardens Florida 33410 —
Winter Haven Winter Haven Florida 33881 —
Emory University Atlanta Georgia 30322 —
Indiana Heart Hospital Indianapolis Indiana 46250 —
Saint Vincents Indianapolis Indianapolis Indiana 46290 —
Community Hospital Munster Indiana 46321 —
Iowa Heart Des Moines Iowa 50314 —
Kansas University Medical Center Kansas City Kansas 66160 —
King's Daughters / Kentucky Heart Foundation Ashland Kentucky 41101 —
Ochsner Clinic Foundation New Orleans Louisiana 70121 —
Maine Medical Center Portland Maine 04102 —
Cape Cod Research Institute Hyannis Massachusetts 02601 —
Detroit Medical Center Detroit Michigan 48201-2018 —
St. John's Hospital Detroit Michigan 48236 —
St. Joseph Mercy Pontiac Michigan 48341 —
Lakeland Saint Joseph Michigan 49085 —
Mercy Hospital Coon Rapids Minnesota 55433 —
Abbott Northwestern Minneapolis Minnesota 55407 —
United Heart & Vascular Saint Paul Minnesota 55102 —
North Mississippi Medical Center Tupelo Mississippi 38801 —
Saint Michaels Newark New Jersey 07102 —
Valley Hospital Ridgewood New Jersey 07450 —
New York Methodist Hospital Brooklyn New York 71878 —
Columbia University Medical Center New York New York 10032 —
Lenox Hill New York New York 10075 —
St. Francis Roslyn New York 11576 —
Good Samaritan Dayton Dayton Ohio 45405 —
Oklahoma Heart Oklahoma City Oklahoma 73120 —
The Heart and Vascular Center Beaver Pennsylvania 15009 —
Bryn Mawr / Lankenau Bryn Mawr Pennsylvania 19010 —
St. Mary's Langhorne Pennsylvania 19047 —
Penn Presbyterian Medical Center Philadelphia Pennsylvania 19104 —
Baptist Memorial Hospital-DeSoto Memphis Tennessee 38120 —
Baylor Dallas Texas 75226 —
Memorial Hermann Houston Texas 77030 —
St. Luke's Houston Texas 77030 —
Davis Hospital Layton Utah 84041 —
Saint Joe Bellingham / North Cascade Cardiology Bellingham Washington 98225 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01092416, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 18, 2023 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01092416 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →